3,4-dihydroxyphenylacetic acid and 2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-

3,4-dihydroxyphenylacetic acid has been researched along with 2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cubeddu, LX; Ferrari, GB; Hoffmann, IS1
Cesura, AM; Colzi, A; d'Agostini, F; Da Prada, M1
Cassis, L; Grohmann, M; Henseling, M; Trendelenburg, U1
Fuller, RW; Hemrick-Luecke, SK1
Clarke, DE; Miller, HH; Shore, PA1
Moy, LY; Sonsalla, PK; Zeevalk, GD1

Other Studies

6 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-

ArticleYear
Metabolism and efflux of [3H]dopamine in rat neostriatum: presynaptic origin of 3,4-[3H]dihydroxyphenylacetic acid.
    The Journal of pharmacology and experimental therapeutics, 1979, Volume: 209, Issue:2

    Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; 3,4-Dihydroxyphenylacetic Acid; Animals; Catechols; Caudate Nucleus; Cocaine; Dopamine; Drug Interactions; In Vitro Techniques; Male; Methylation; Phenylacetates; Probenecid; Putamen; Rats; Synapses

1979
Brain microdialysis in rats: a technique to reveal competition in vivo between endogenous dopamine and moclobemide, a RIMA antidepressant.
    Psychopharmacology, 1992, Volume: 106 Suppl

    Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; 3,4-Dihydroxyphenylacetic Acid; Animals; Benzamides; Binding, Competitive; Brain Chemistry; Dialysis; Dopamine; Male; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurons; Rats; Rats, Inbred Strains; Thiazoles

1992
Errors introduced by a tritium label in position 8 of catecholamines.
    Naunyn-Schmiedeberg's archives of pharmacology, 1986, Volume: 332, Issue:1

    Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; 3,4-Dihydroxyphenylacetic Acid; Animals; Aorta, Thoracic; Catecholamines; Deamination; In Vitro Techniques; Isotope Labeling; Male; Mandelic Acids; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Muscle, Smooth; Myocardium; Neurons; Norepinephrine; Phenylethyl Alcohol; Rabbits; Rats; Vas Deferens

1986
Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    The Journal of pharmacology and experimental therapeutics, 1985, Volume: 232, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dextroamphetamine; Dogs; Dopamine; Homovanillic Acid; In Vitro Techniques; Kinetics; Liver; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Pyridines; Rats; Rats, Inbred Strains

1985
In vivo monoamine oxidase inhibition by d-amphetamine.
    Biochemical pharmacology, 1980, May-15, Volume: 29, Issue:10

    Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Brain; Cocaine; Corpus Striatum; Dextroamphetamine; Haloperidol; Male; Monoamine Oxidase Inhibitors; Phenelzine; Rats

1980
Role for dopamine in malonate-induced damage in vivo in striatum and in vitro in mesencephalic cultures.
    Journal of neurochemistry, 2000, Volume: 74, Issue:4

    Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Animals; Biological Transport; Carbon Radioisotopes; Cells, Cultured; Corpus Striatum; Dopamine; Energy Metabolism; Free Radicals; gamma-Aminobutyric Acid; Lactic Acid; Male; Malonates; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Microdialysis; Nerve Degeneration; Neurons; Neuropeptides; Parkinson Disease; Presynaptic Terminals; Synaptic Vesicles; Tetrabenazine; Tritium; Vesicular Biogenic Amine Transport Proteins

2000